New Zealand chemists present new research findings at Pacifichem 2000

December 18, 2000

Papers are embargoed until date and time of presentation.

Click here for Abstract 1, here for Abstract 2, and here for Abstract 3.

HONOLULU - The latest research from New Zealand scientists will be presented at the 2000 International Chemical Congress of Pacific Basin Societies, December 14-19, 2000.

The weeklong scientific meeting, held once every five years, is hosted by the American Chemical Society, in conjunction with its counterparts in Australia, Canada, Japan and New Zealand.

New Zealand chemists will present new findings on topics including (papers are embargoed for release until date and time of presentation):

Meat storage - If you'd like a more mouth-watering leg-of-lamb, pay attention to this study: Responding to reports that long-term chilled storage ruins the flavor and odor of raw sheep meat, researchers investigated different meat-packaging systems and discovered that freezing is the best way to store the meat. Chilling, they found, apparently increases spoiling and decreases sweetness, especially over time. (AGRO 115, 9:05 a.m., Saturday, Dec. 16)

Native Asian kozo tree
- Researchers at the University of Auckland have isolated a chemical from a native Asian tree that appears to be promising for the treatment of AIDS, cancer and diabetes. Commonly known as kozo (Broussonetia kazinoki), the tree's parts are used in some countries for folk medicine and paper products. (ORGN 1843, 9 a.m., Monday, Dec. 18)

Marine sponges - Researchers at the University of Canterbury have discovered a host of potentially useful compounds in marine sponges, including some that may help fight AIDS and cancer. The future development of these products may depend on the efforts of researchers to strike a balance between emerging technology and the ongoing problem of limited natural resources. (ORGN 1730, 7:05 p.m., Monday, Dec. 18)

More than 8,000 research papers will be presented during this year's International Chemical Congress, which is sponsored jointly by the ACS, the Chemical Society of Japan, the Canadian Society of Chemistry, the Royal Australian Chemical Institute and the New Zealand Institute of Chemistry.

American Chemical Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to